Superovulation in mice comprising administration of anti-inhibin serum and equine chorionic gonadotropin
AssigneeNational University Corporation Kumamoto University
InventorsNaomi Nakagata, Toru Takeo
Life of this patent
Estimating the term…
Abstract
An object of the present invention is to provide a novel method that is excellent in superovulation induction efficiency. Specifically, it is an object to provide a method giving superior superovulation induction efficiency as compared with conventional methods using equine chorionic gonadotropin (eCG) and human chorionic gonadotropin (hCG). The present invention provides a superovulation inducing method, comprising simultaneously administering anti-inhibin antibody and equine chorionic gonadotropin (eCG), then, administering human chorionic gonadotropin (hCG), to a female mouse.
Claims14
A superovulation inducing method, comprising simultaneously administering to a female mouse (a) anti-inhibin antibody and equine chorionic gonadotropin (eCG), (b) followed by human chorionic gonadotropin (hCG).
Dependencies are inferred from the claim text.